---
figid: PMC7510328__13046_2020_1711_Fig2_HTML
figlink: pmc/articles/PMC7510328/figure/Fig2/
number: F2
caption: Mechanisms of MET and/or RON activation, signaling pathway, and biological
  consequence. Activation of MET and/or RON in CRAC cells, in general, is mediated
  through five events including ligand binding, activating mutation, receptor overexpression,
  aberrant splicing/alternative initiation, and transactivation through other RTKs
  such as EGFR and IGF-1R. HGF or MSP-induced MET and/or RON activation, a classical
  model, is functional through phosphorylation of several critical tyrosine residues
  and creates the C-terminal functional docking site, which recruits cytoplasmic molecules
  such as SOS and GRB2. The negative modulator c-CBL, a ubiquitin ligase, also binds
  the docking site and mediates MET and/or RON endocytosis and degradation. Multiple
  signaling pathways, such as RAS/MAP kinase, PI3K/AKT, Wnt/β-catenin, and TGF-β/SMAD
  pathways are activated upon MET and/or RON phosphorylation in CRAC cells, which
  creates a complex intracellular signaling network. The biological consequence is
  induction of EMT in CRAC cells leading to increased cellular survival, invasiveness,
  chemoresistance, and tumorigenic stemness. Briefly, activation of the RAS/MAP kinase
  cascade stimulates MET and/or RON-mediated activities such as cellular survival,
  invasiveness, chemoresistance, and tumorigenic stemness through regulating various
  gene expressions and cellular activities. Activated Erk1/2 also stimulates RSK-2,
  which regulates not only gene transcription but also cytoskeleton re-organization
  to cause the EMT-like phenotype. The PI3K-AKT pathway is essential in MET and/or
  RON-mediated cellular invasive growth and chemoresistance. Activated AKT inhibits
  GSK-3β by phosphorylation, resulting in MET and/or RON signaling cross-talking with
  the β-catenin pathway. AKT signaling is also linked to MET and/or RON-induced mTOR
  phosphorylation, which releases HIF-1α from the VHL. Similarly, mTOR stimulates
  p70S6 kinase, which activates certain transcription factors leading to increased
  gene expression. AKT also stimulates 14-3-3 phosphorylation, which displaces α6β4
  integrin from its location at hemidesmosomes and re-localizes it to lamellipodia
  for cell motility. MET and/or RON activation also collaborates with TGF-β mediated
  Smad2/3 signaling and regulates CRAC cell EMT-like phenotypes, leading to cellular
  senescence, migration, and chemoresistance. Studies also show that MET and/or RON
  activation regulate β-catenin dephosphorylation by activating DVL, leading to β-catenin
  accumulation and nuclear translocation for activating gene transcription. ABL, Abelson
  murine leukemia viral oncogene homolog; AKT, BCL-2, B cell lymphoma-2; BIM, Bcl-2-like
  protein 11; CBL, protein kinase B; APC, adenomatous polyposis coli; AXIN, axis inhibition
  protein; CBP, CREB-binding protein; CREB, cAMP response element-binding protein;
  DVL, disheveled; Erk, extracellular signal-regulated kinase; FRAP, FKBP12-rapamycin-associated
  protein; FOXO3a, forkhead box O3; GRB2, growth factor receptor-bound protein; GSK,
  glycogen synthase kinase; MCL-1, myeloid cell leukemia 1; MEK, mitogen-activated
  protein kinase-kinase; MNK, mitogen-activated protein kinase interacting protein;
  mTOR, mammalian target of rapamycin; P70S6K, rribosomal protein S6 kinase beta-1;
  PDK1, 3-phosphoinositide-dependent protein kinase-1; PI3K, phosphatidyl-inositol
  3 kinase; Raf, rapidly accelerated fibrosarcoma; RAS, reticular activating system;
  RSK-2, p90 ribosomal S6 kinase-2; Smad, small mothers against decapentaplegic; SOS,
  son of sevenless; TGF, transforming growth factor; VHL, von Hippel-Lindau protein
pmcid: PMC7510328
papertitle: 'MET and RON receptor tyrosine kinases in colorectal adenocarcinoma: molecular
  features as drug targets and antibody-drug conjugates for therapy.'
reftext: Hang-Ping Yao, et al. J Exp Clin Cancer Res. 2020;39:198.
pmc_ranked_result_index: '89656'
pathway_score: 0.9122034
filename: 13046_2020_1711_Fig2_HTML.jpg
figtitle: MET and/or RON activation, signaling pathway, and biological consequence
year: '2020'
organisms:
- Mus musculus
- Rattus norvegicus
- Macaca fascicularis
- Homo sapiens
- Canis lupus familiaris
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7510328__13046_2020_1711_Fig2_HTML.html
  '@type': Dataset
  description: Mechanisms of MET and/or RON activation, signaling pathway, and biological
    consequence. Activation of MET and/or RON in CRAC cells, in general, is mediated
    through five events including ligand binding, activating mutation, receptor overexpression,
    aberrant splicing/alternative initiation, and transactivation through other RTKs
    such as EGFR and IGF-1R. HGF or MSP-induced MET and/or RON activation, a classical
    model, is functional through phosphorylation of several critical tyrosine residues
    and creates the C-terminal functional docking site, which recruits cytoplasmic
    molecules such as SOS and GRB2. The negative modulator c-CBL, a ubiquitin ligase,
    also binds the docking site and mediates MET and/or RON endocytosis and degradation.
    Multiple signaling pathways, such as RAS/MAP kinase, PI3K/AKT, Wnt/β-catenin,
    and TGF-β/SMAD pathways are activated upon MET and/or RON phosphorylation in CRAC
    cells, which creates a complex intracellular signaling network. The biological
    consequence is induction of EMT in CRAC cells leading to increased cellular survival,
    invasiveness, chemoresistance, and tumorigenic stemness. Briefly, activation of
    the RAS/MAP kinase cascade stimulates MET and/or RON-mediated activities such
    as cellular survival, invasiveness, chemoresistance, and tumorigenic stemness
    through regulating various gene expressions and cellular activities. Activated
    Erk1/2 also stimulates RSK-2, which regulates not only gene transcription but
    also cytoskeleton re-organization to cause the EMT-like phenotype. The PI3K-AKT
    pathway is essential in MET and/or RON-mediated cellular invasive growth and chemoresistance.
    Activated AKT inhibits GSK-3β by phosphorylation, resulting in MET and/or RON
    signaling cross-talking with the β-catenin pathway. AKT signaling is also linked
    to MET and/or RON-induced mTOR phosphorylation, which releases HIF-1α from the
    VHL. Similarly, mTOR stimulates p70S6 kinase, which activates certain transcription
    factors leading to increased gene expression. AKT also stimulates 14-3-3 phosphorylation,
    which displaces α6β4 integrin from its location at hemidesmosomes and re-localizes
    it to lamellipodia for cell motility. MET and/or RON activation also collaborates
    with TGF-β mediated Smad2/3 signaling and regulates CRAC cell EMT-like phenotypes,
    leading to cellular senescence, migration, and chemoresistance. Studies also show
    that MET and/or RON activation regulate β-catenin dephosphorylation by activating
    DVL, leading to β-catenin accumulation and nuclear translocation for activating
    gene transcription. ABL, Abelson murine leukemia viral oncogene homolog; AKT,
    BCL-2, B cell lymphoma-2; BIM, Bcl-2-like protein 11; CBL, protein kinase B; APC,
    adenomatous polyposis coli; AXIN, axis inhibition protein; CBP, CREB-binding protein;
    CREB, cAMP response element-binding protein; DVL, disheveled; Erk, extracellular
    signal-regulated kinase; FRAP, FKBP12-rapamycin-associated protein; FOXO3a, forkhead
    box O3; GRB2, growth factor receptor-bound protein; GSK, glycogen synthase kinase;
    MCL-1, myeloid cell leukemia 1; MEK, mitogen-activated protein kinase-kinase;
    MNK, mitogen-activated protein kinase interacting protein; mTOR, mammalian target
    of rapamycin; P70S6K, rribosomal protein S6 kinase beta-1; PDK1, 3-phosphoinositide-dependent
    protein kinase-1; PI3K, phosphatidyl-inositol 3 kinase; Raf, rapidly accelerated
    fibrosarcoma; RAS, reticular activating system; RSK-2, p90 ribosomal S6 kinase-2;
    Smad, small mothers against decapentaplegic; SOS, son of sevenless; TGF, transforming
    growth factor; VHL, von Hippel-Lindau protein
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HGF
  - MET
  - EGFR
  - IGF1R
  - MST1R
  - CBL
  - SOS1
  - SOS2
  - HRAS
  - KRAS
  - NRAS
  - GRB2
  - MAPK14
  - MAPK3
  - MAPK8
  - MAPK11
  - MAPK13
  - MAPK12
  - MAPK1
  - MAPK9
  - MAPK10
  - MAK
  - CTNNB1
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - SMAD1
  - SMAD2
  - SMAD5
  - SMAD6
  - SMAD9
  - SMAD3
  - SMAD4
  - SMAD7
  - DVL3
  - DVL1
  - DVL2
  - PDK1
  - APC
  - ARAF
  - BRAF
  - RAF1
  - GSK3A
  - GSK3B
  - AXIN1
  - AXIN2
  - CSNK1A1
  - MTOR
  - MAP2K1
  - MAP2K2
  - YWHAQ
  - BCL2
  - ATP7A
  - VHL
  - HIF1A
  - BCL2L11
  - RPS6KA3
  - OPN1LW
  - MCL1
  - RPS6KB1
  - RPS6KB2
  - VHL
  - Stemness
genes:
- word: HGF
  symbol: HGF
  source: hgnc_symbol
  hgnc_symbol: HGF
  entrez: '3082'
- word: MET
  symbol: MET
  source: hgnc_symbol
  hgnc_symbol: MET
  entrez: '4233'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: IGF-1R
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: RON
  symbol: RON
  source: hgnc_prev_symbol
  hgnc_symbol: MST1R
  entrez: '4486'
- word: c-Cbl
  symbol: c-Cbl
  source: hgnc_alias_symbol
  hgnc_symbol: CBL
  entrez: '867'
- word: c-Cbl
  symbol: c-Cbl
  source: hgnc_alias_symbol
  hgnc_symbol: CBL
  entrez: '867'
- word: c-Cbl
  symbol: c-Cbl
  source: hgnc_alias_symbol
  hgnc_symbol: CBL
  entrez: '867'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: SoS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: SoS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: SoS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: SoS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: GRB2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: GRB2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: GRB2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: GRB2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: МАРК
  symbol: MAK
  source: hgnc_symbol
  hgnc_symbol: MAK
  entrez: '4117'
- word: B-catenin
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI-3k
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI-3k
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI-3k
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI-3k
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI-3k
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI-3k
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI-3k
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI-3k
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD1
  entrez: '4086'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD5
  entrez: '4090'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD6
  entrez: '4091'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD9
  entrez: '4093'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD7
  entrez: '4092'
- word: RAS-GTP
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS-GTP
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS-GTP
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: DVL
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL3
  entrez: '1857'
- word: DVL
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL1
  entrez: '1855'
- word: DVL
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL2
  entrez: '1856'
- word: RAS-GTP
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS-GTP
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS-GTP
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Erk1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Erk1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Smad4
  symbol: SMAD4
  source: hgnc_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: АРС
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: GSK-3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: GSK-3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: AXIN
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN1
  entrez: '8312'
- word: AXIN
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN2
  entrez: '8313'
- word: Smad2/3
  symbol: SMAD2
  source: hgnc_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: Smad2/3
  symbol: SMAD3
  source: hgnc_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: CKla
  symbol: CK1a
  source: hgnc_alias_symbol
  hgnc_symbol: CSNK1A1
  entrez: '1452'
- word: CKla
  symbol: CKIa
  source: hgnc_alias_symbol
  hgnc_symbol: CSNK1A1
  entrez: '1452'
- word: GSK-3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: GSK-3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: Smad2/3
  symbol: SMAD2
  source: hgnc_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: Smad2/3
  symbol: SMAD3
  source: hgnc_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: 14-3-3
  symbol: 14-3-3
  source: hgnc_alias_symbol
  hgnc_symbol: YWHAQ
  entrez: '10971'
- word: B-catenin
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: FRAP
  symbol: FRAP
  source: hgnc_prev_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: B-catenin
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: BCL2
  symbol: BCL2
  source: hgnc_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: Smad2/3
  symbol: SMAD2
  source: hgnc_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: Smad2/3
  symbol: SMAD3
  source: hgnc_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: Smad4
  symbol: SMAD4
  source: hgnc_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: Erk1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Erk1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Smad2/3
  symbol: SMAD2
  source: hgnc_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: Smad2/3
  symbol: SMAD3
  source: hgnc_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: MNK
  symbol: MNK
  source: hgnc_prev_symbol
  hgnc_symbol: ATP7A
  entrez: '538'
- word: VHL
  symbol: VHL
  source: hgnc_symbol
  hgnc_symbol: VHL
  entrez: '7428'
- word: HIF-1a
  symbol: HIF1A
  source: hgnc_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: B-catenin
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: B-catenin
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: BIM
  symbol: BIM
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L11
  entrez: '10018'
- word: B-catenin
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: RSK-1/2
  symbol: RSK2
  source: hgnc_alias_symbol
  hgnc_symbol: RPS6KA3
  entrez: '6197'
- word: СВР
  symbol: CBP
  source: hgnc_prev_symbol
  hgnc_symbol: OPN1LW
  entrez: '5956'
- word: MCL1
  symbol: MCL1
  source: hgnc_symbol
  hgnc_symbol: MCL1
  entrez: '4170'
- word: P70S6K
  symbol: P70S6K
  source: bioentities_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
- word: P70S6K
  symbol: P70S6K
  source: bioentities_symbol
  hgnc_symbol: RPS6KB2
  entrez: '6199'
- word: B-catenin
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: Smad4
  symbol: SMAD4
  source: hgnc_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: Smad1/5/8
  symbol: SMAD5
  source: hgnc_symbol
  hgnc_symbol: SMAD5
  entrez: '4090'
- word: Smad1/5/8
  symbol: SMAD8
  source: hgnc_alias_symbol
  hgnc_symbol: SMAD9
  entrez: '4093'
- word: Smad1/5/8
  symbol: SMAD1
  source: hgnc_symbol
  hgnc_symbol: SMAD1
  entrez: '4086'
- word: Smad1/5/8
  symbol: SMAD5
  source: hgnc_symbol
  hgnc_symbol: SMAD5
  entrez: '4090'
- word: Smad1/5/8
  symbol: SMAD8
  source: hgnc_alias_symbol
  hgnc_symbol: SMAD9
  entrez: '4093'
- word: Smad1/5/8
  symbol: SMAD1
  source: hgnc_symbol
  hgnc_symbol: SMAD1
  entrez: '4086'
- word: Smad1/5/8
  symbol: SMAD5
  source: hgnc_symbol
  hgnc_symbol: SMAD5
  entrez: '4090'
- word: Smad1/5/8
  symbol: SMAD8
  source: hgnc_alias_symbol
  hgnc_symbol: SMAD9
  entrez: '4093'
- word: Smad1/5/8
  symbol: SMAD1
  source: hgnc_symbol
  hgnc_symbol: SMAD1
  entrez: '4086'
- word: Smad1/5/8
  symbol: SMAD5
  source: hgnc_symbol
  hgnc_symbol: SMAD5
  entrez: '4090'
- word: Smad1/5/8
  symbol: SMAD8
  source: hgnc_alias_symbol
  hgnc_symbol: SMAD9
  entrez: '4093'
- word: Smad1/5/8
  symbol: SMAD1
  source: hgnc_symbol
  hgnc_symbol: SMAD1
  entrez: '4086'
chemicals: []
diseases:
- word: VHL
  source: MESH
  identifier: D006623
- word: Stemness
  source: MESH
  identifier: D020295
figid_alias: PMC7510328__F2
redirect_from: /figures/PMC7510328__F2
figtype: Figure
---
